Holen Sie sich die Stockscreener-App
18.59
0.03%
-0.0172
Schlusskurs vom Vortag:
$18.61
Offen:
$18.83
24-Stunden-Volumen:
256.14K
Relative Volume:
0.26
Marktkapitalisierung:
$1.37B
Einnahmen:
$193.35M
Nettoeinkommen (Verlust:
$-177.58M
KGV:
-7.5889
EPS:
-2.45
Netto-Cashflow:
$-172.43M
1W Leistung:
+3.48%
1M Leistung:
+4.70%
6M Leistung:
-14.20%
1J Leistung:
-8.48%
1-Tages-Spanne:
$18.38
$18.85
1-Wochen-Bereich:
$18.05
$19.58
52-Wochen-Spanne:
$15.99
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Vergleichen Sie SDGR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
18.62 | 1.37B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
241.41 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
67.30 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.76 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.77 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrödinger (SDGR) Partners with Eli Lilly for AI-Driven Drug Di - GuruFocus
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software - Reuters
Lilly joins Schrödinger, Revvity for AI drug discovery (update) - Seeking Alpha
Schrödinger (SDGR) Partners with Eli Lilly for AI Drug Discovery - GuruFocus
Eli Lilly joins Schrödinger in AI drug discovery (SDGR:NASDAQ) - Seeking Alpha
Schrödinger partners with Lilly TuneLab to enhance drug discovery By Investing.com - Investing.com India
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign - itemonline.com
Will Schrödinger Inc. stock recover faster than peersWeekly Trend Recap & Risk Managed Investment Signals - ulpravda.ru
Will Schrödinger Inc. stock beat EPS estimatesWeekly Trading Summary & Real-Time Price Movement Reports - ulpravda.ru
Is Schrödinger Inc. stock gaining market shareEarnings Recap Report & Reliable Volume Spike Alerts - ulpravda.ru
Whale Trades: Will Schrödinger Inc. stock benefit from automationQuarterly Profit Report & Accurate Buy Signal Alerts - ulpravda.ru
Schrodinger (SDGR): TD Cowen Maintains Buy Rating, Lowers Price Target | SDGR Stock News - GuruFocus
Why Schrödinger Inc. stock is rated strong buyJuly 2025 Update & Free Real-Time Volume Trigger Notifications - ulpravda.ru
KeyBanc Maintains Overweight Rating for SDGR but Lowers Price Ta - GuruFocus
Why Schrödinger Inc. stock could be next big winnerBull Market Opportunities & Affordable Trading Growth - ulpravda.ru
UBS Initiates Coverage of Schrödinger (SDGR) with Neutral Recommendation - Nasdaq
SDGR: UBS Initiates Coverage with Neutral Rating | SDGR Stock Ne - GuruFocus
Schrodinger stock initiated with Neutral rating at UBS on growth concerns By Investing.com - Investing.com South Africa
Schrodinger stock initiated with Neutral rating at UBS on growth concerns - Investing.com Nigeria
Materials Informatics Market Size to Hit USD 736.71 Million by 2035 - GlobeNewswire Inc.
Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now - MSN
Do Options Traders Know Something About Schrodinger Stock We Don't? - MSN
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform - The Globe and Mail
Schrödinger (SDGR) Valuation Check After Analyst Upgrades Back Its Software-Focused Strategic Pivot - Yahoo Finance
Schrödinger (SDGR) Is Up 6.5% After Refocusing On Core Software Business And Analyst UpgradesHas The Bull Case Changed? - Yahoo Finance
Schrödinger (SDGR) Is Up 6.5% After Refocusing On Core Software Platform Over Drug DevelopmentWhat's Changed - simplywall.st
Liquidity Mapping Around (SDGR) Price Events - Stock Traders Daily
Schrodinger (NASDAQ:SDGR) Trading Up 8.9%Time to Buy? - MarketBeat
BofA Upgrades Schrodinger (SDGR) to Buy After Strategic Pivot to Software - Finviz
BofA Upgrades Schrödinger (SDGR) to Buy After Strategic Pivot to Software - Insider Monkey
Is Schrödinger Inc. (43Z) stock among top earnings playsJuly 2025 Chart Watch & Comprehensive Market Scan Reports - Улправда
Panic Selling: Is Schrödinger Inc. (43Z) stock among top earnings playsWeekly Market Report & Stepwise Swing Trade Plans - Улправда
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - Yahoo Finance
How Schrödinger Inc. stock trades before earnings2025 Fundamental Recap & Growth Focused Stock Reports - Улправда
Is Schrödinger Inc. stock a buy for dividend growth2025 Biggest Moves & Verified Technical Trade Signals - Улправда
Schrodinger Earnings Notes - Trefis
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)December 17, 2025 - BioSpace
Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Schrodinger upgraded to Buy from Neutral at BofA - MSN
Schrödinger reports inducement grants under Nasdaq listing - marketscreener.com
Schrödinger Reports Inducement Grants Under Nasdaq Listing - TradingView — Track All Markets
Schrodinger Shares Rise After BofA Securities Upgrade - marketscreener.com
Schrodinger (SDGR) Upgraded to Buy by B of A Securities | SDGR S - GuruFocus
Schrodinger (NASDAQ:SDGR) Shares Gap Up After Analyst Upgrade - MarketBeat
BofA Securities upgrades Schrodinger stock rating to Buy from Neutral By Investing.com - Investing.com Nigeria
B of A Securities Upgrades Schrödinger (SDGR) - Nasdaq
Bank of America Upgrades Schrodinger (NASDAQ:SDGR) to "Buy" - MarketBeat
BofA Securities upgrades Schrodinger stock rating to Buy from Neutral - Investing.com India
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):